Literature DB >> 9986885

Elastin mutation and cardiac disease.

T Chowdhury1, W Reardon.   

Abstract

Characterization of the molecular basis of structural cardiac disease includes elucidating the pathogenesis of certain vascular disease by demonstrating mutations of the Elastin gene as the cause of familial supravalvular aortic stenosis (SVAS) and Williams' syndrome (WS). Defining the etiology of SVAS has clinical implications in terms of prenatal and presymptomatic diagnosis and possible earlier intervention with medical therapy. This review considers the evidence relating Elastin mutations to SVAS and WS and outlines the possible mechanisms by which these mutations give rise to cardiac disease. Finally, the implications which Elastin mutation identification has on current clinical practice and future research directions are considered.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9986885     DOI: 10.1007/s002469900415

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  11 in total

1.  Decreased elastin in vessel walls puts the pressure on.

Authors:  Jeanine D'Armiento
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

2.  NMR studies of localized water and protein backbone dynamics in mechanically strained elastin.

Authors:  Cheng Sun; Odingo Mitchell; Jiaxin Huang; Gregory S Boutis
Journal:  J Phys Chem B       Date:  2011-11-07       Impact factor: 2.991

3.  Elastin mutation screening in a group of patients affected by vascular abnormalities.

Authors:  L Rodriguez-Revenga; C Badenas; A Carrió; M Milà
Journal:  Pediatr Cardiol       Date:  2005 Nov-Dec       Impact factor: 1.655

Review 4.  Vascular wall extracellular matrix proteins and vascular diseases.

Authors:  Junyan Xu; Guo-Ping Shi
Journal:  Biochim Biophys Acta       Date:  2014-07-18

5.  Endogenous Optical Signals Reveal Changes of Elastin and Collagen Organization During Differentiation of Mouse Embryonic Stem Cells.

Authors:  Terra N Thimm; Jayne M Squirrell; Yuming Liu; Kevin W Eliceiri; Brenda M Ogle
Journal:  Tissue Eng Part C Methods       Date:  2015-06-17       Impact factor: 3.056

6.  Cardiac catheterization and operative outcomes from a multicenter consortium for children with williams syndrome.

Authors:  Phat P Pham; James H Moller; Christine Hills; Virgil Larson; Lee Pyles
Journal:  Pediatr Cardiol       Date:  2008-12-04       Impact factor: 1.655

7.  Identification and characterization of seven novel mutations of elastin gene in a cohort of patients affected by supravalvular aortic stenosis.

Authors:  Lucia Micale; Maria Giuseppina Turturo; Carmela Fusco; Bartolomeo Augello; Luis A Pérez Jurado; Claudia Izzi; Maria Cristina Digilio; Donatella Milani; Elisabetta Lapi; Leopoldo Zelante; Giuseppe Merla
Journal:  Eur J Hum Genet       Date:  2009-10-21       Impact factor: 4.246

8.  Elastin haploinsufficiency induces alternative aging processes in the aorta.

Authors:  Mylène Pezet; Marie-Paule Jacob; Brigitte Escoubet; Dealba Gheduzzi; Emmanuelle Tillet; Pascale Perret; Philippe Huber; Daniela Quaglino; Roger Vranckx; Dean Y Li; Barry Starcher; Walter A Boyle; Robert P Mecham; Gilles Faury
Journal:  Rejuvenation Res       Date:  2008-02       Impact factor: 4.663

9.  Growth of the aorta in children with Williams syndrome: does surgery make a difference?

Authors:  R F English; S D Colan; P M Kanani; J A Ettedgui
Journal:  Pediatr Cardiol       Date:  2003-04-30       Impact factor: 1.655

10.  Minoxidil versus placebo in the treatment of arterial wall hypertrophy in children with Williams Beuren Syndrome: a randomized controlled trial.

Authors:  Behrouz Kassai; Philippe Bouyé; Brigitte Gilbert-Dussardier; François Godart; Jean-Benoit Thambo; Massimiliano Rossi; Pierre Cochat; Pierre Chirossel; Stephane Luong; André Serusclat; Isabelle Canterino; Catherine Mercier; Muriel Rabilloud; Christine Pivot; Fabrice Pirot; Tiphanie Ginhoux; Stéphanie Coopman; Guillaume Grenet; François Gueyffier; Sylvie Di-Fillippo; Aurélia Bertholet-Thomas
Journal:  BMC Pediatr       Date:  2019-05-28       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.